THE NATURAL-HISTORY OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) - A PROSPECTIVE-STUDY

被引:1438
作者
RANGELFRAUSTO, MS
PITTET, D
COSTIGAN, M
HWANG, T
DAVIS, CS
WENZEL, RP
机构
[1] UNIV IOWA,COLL MED,DEPT INTERNAL MED,DIV GEN MED CLIN EPIDEMIOL & HLTH SERV RES,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,DEPT PREVENT MED,DIV BIOSTAT,IOWA CITY,IA 52242
[3] UNIV HOSP GENEVA,DEPT INTERNAL MED,DIV INFECT DIS,INFECT CONTROL GRP,GENEVA,SWITZERLAND
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1995年 / 273卷 / 02期
关键词
D O I
10.1001/jama.273.2.117
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-Define the epidemiology of the four recently classified syndromes describing the biologic response to infection: systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic shock. Design.-Prospective cohort study with a follow-up of 28 days or until discharge if earlier. Setting.-Three intensive care units and three general wards in a tertiary health care institution. Methods.-Patients were included if they met at least two of the criteria for SI RS: fever or hypothermia, tachycardia, tachypnea, or abnormal white blood cell count. Main Outcomes Measures.-Development of any stage of the biologic response to infection: sepsis, severe sepsis, septic shock, end-organ dysfunction, and death. Results.-During the study period 3708 patients were admitted to the survey units, and 2527 (68%) met the criteria for SIRS. The incidence density rates for SIRS in the surgical, medical, and cardiovascular intensive care units were 857, 804, and 542 episodes per 1000 patient-days, respectively, and 671, 495, and 320 per 1000 patient-days for the medical, cardiothoracic, and general surgery wards, respectively. Among patients with SIRS, 649 (26%) developed sepsis, 467 (18%) developed severe sepsis, and 110 (4%) developed septic shock. The median interval from SIRS to sepsis was inversely correlated with the number of SIRS criteria (two, three, or all four) that the patients met. As the population of patients progressed from SIRS to septic shock, increasing proportions had adult respiratory distress syndrome, disseminated intravascular coagulation, acute renal failure, and shock. Positive blood cultures were found in 17% of patients with sepsis, in 25% with severe sepsis, and in 69% with septic shock, There were also stepwise increases in mortality rates in the hierarchy from SIRS, sepsis, severe sepsis, and septic shock: 7%, 16%, 20%, and 46%, respectively. Of interest, we also observed equal numbers of patients who appeared to have sepsis, severe sepsis, and septic shock but who had negative cultures. They had been prescribed empirical antibiotics for a median of 3 days, The cause of the systemic inflammatory response in these culture-negative populations is unknown, but they had similar morbidity and mortality rates as the respective culture-positive populations. Conclusions.-This prospective epidemiologic study of SIRS and related conditions provides, to our knowledge, the first evidence of a clinical progression from SIRS to sepsis to severe sepsis and septic shock.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 29 条
  • [1] [Anonymous], 1992, CRIT CARE MED, V20, P864
  • [2] Bone R C, 1991, Infect Dis Clin North Am, V5, P793
  • [3] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) : 653 - 658
  • [4] SEPSIS SYNDROME - A VALID CLINICAL ENTITY
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (05) : 389 - 393
  • [6] NOSOCOMIAL INFECTIONS - VALIDATION OF SURVEILLANCE AND COMPUTER MODELING TO IDENTIFY PATIENTS AT RISK
    BRODERICK, A
    MORI, M
    NETTLEMAN, MD
    STREED, SA
    WENZEL, RP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (04) : 734 - 742
  • [7] MONOCLONAL-ANTIBODY TO TNF IN SEVERE SEPTIC SHOCK
    EXLEY, AR
    COHEN, J
    BUURMAN, W
    OWEN, R
    LUMLEY, J
    BODMER, M
    STEPHENS, S
    HANSON, G
    AULAKH, JM
    RIDDELL, A
    PERRY, M
    [J]. LANCET, 1990, 335 (8700) : 1275 - 1277
  • [8] PREVALENCE, INCIDENCE AND DURATION
    FREEMAN, J
    HUTCHISON, GB
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1980, 112 (05) : 707 - 723
  • [9] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS
    GREENMAN, RL
    SCHEIN, RMH
    MARTIN, MA
    WENZEL, RP
    MACINTYRE, NR
    EMMANUEL, G
    CHMEL, H
    KOHLER, RB
    MCCARTHY, M
    PLOUFFE, J
    RUSSELL, JA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08): : 1097 - 1102
  • [10] KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P10